Literature DB >> 21641483

Bilirubin injury to neurons and glial cells: new players, novel targets, and newer insights.

Dora Brites1.   

Abstract

Encephalopathy by hyperbilirubinemia in infants has been described for decades, but neither the underlying cellular and molecular mechanisms nor the selective pattern of bilirubin deposition in the brain is well understood. The brain is composed of highly specialized and diverse populations of cells, represented by neurons and glia that comprise astrocytes, oligodendrocytes, and microglia. Although microscopic evaluation of icteric brain sections revealed bilirubin within neurons, neuronal processes, and microglia, cell dependent-sensitivity to bilirubin toxicity and the role of each nerve cell type are poorly understood. Even less considered are glial and neuronal pathologic alterations as integrated phenomena. The available knowledge on reactivity of glial cells to bilirubin and on the impairment to neuronal network dynamics that it causes, here summarized, suggests that a better comprehension of the interplay between neurons and glia is essential to understand bilirubin neurotoxicity and highlight potential molecular targets that may lead to disease-modifying therapeutic approaches.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21641483     DOI: 10.1053/j.semperi.2011.02.004

Source DB:  PubMed          Journal:  Semin Perinatol        ISSN: 0146-0005            Impact factor:   3.300


  20 in total

1.  ER stress, mitochondrial dysfunction and calpain/JNK activation are involved in oligodendrocyte precursor cell death by unconjugated bilirubin.

Authors:  Andreia Barateiro; Ana Rita Vaz; Sandra Leitão Silva; Adelaide Fernandes; Dora Brites
Journal:  Neuromolecular Med       Date:  2012-06-17       Impact factor: 3.843

Review 2.  Bilirubin Encephalopathy.

Authors:  Shuo Qian; Prateek Kumar; Fernando D Testai
Journal:  Curr Neurol Neurosci Rep       Date:  2022-05-19       Impact factor: 5.081

3.  Cross-talk between neurons and astrocytes in response to bilirubin: early beneficial effects.

Authors:  Ana Sofia Falcão; Rui F M Silva; Ana Rita Vaz; Sandra Leitão Silva; Adelaide Fernandes; Dora Brites
Journal:  Neurochem Res       Date:  2013-01-03       Impact factor: 3.996

Review 4.  High unbound bilirubin for age: a neurotoxin with major effects on the developing brain.

Authors:  Rowena Cayabyab; Rangasamy Ramanathan
Journal:  Pediatr Res       Date:  2018-12-05       Impact factor: 3.756

Review 5.  Developmental influence of unconjugated hyperbilirubinemia and neurobehavioral disorders.

Authors:  Sanjiv B Amin; Tristram Smith; Geralyn Timler
Journal:  Pediatr Res       Date:  2018-10-23       Impact factor: 3.756

6.  The evolving landscape of neurotoxicity by unconjugated bilirubin: role of glial cells and inflammation.

Authors:  Dora Brites
Journal:  Front Pharmacol       Date:  2012-05-29       Impact factor: 5.810

7.  PPARα: A Master Regulator of Bilirubin Homeostasis.

Authors:  Cyril Bigo; Jenny Kaeding; Diala El Husseini; Iwona Rudkowska; Mélanie Verreault; Marie Claude Vohl; Olivier Barbier
Journal:  PPAR Res       Date:  2014-07-23       Impact factor: 4.964

8.  A Hypothesis for Using Pathway Genetic Load Analysis for Understanding Complex Outcomes in Bilirubin Encephalopathy.

Authors:  Sean M Riordan; Douglas C Bittel; Jean-Baptiste Le Pichon; Silvia Gazzin; Claudio Tiribelli; Jon F Watchko; Richard P Wennberg; Steven M Shapiro
Journal:  Front Neurosci       Date:  2016-08-18       Impact factor: 4.677

9.  Hyperbilirubinemia exaggerates endotoxin-induced hypothermia.

Authors:  Eszter Pakai; Andras Garami; Tatiane B Nucci; Andrei I Ivanov; Andrej A Romanovsky
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

10.  Metyrapone, an inhibitor of cytochrome oxidases, does not affect viability in a neuroblastoma cell model of bilirubin toxicity.

Authors:  Maria N Naguib Leerberg; Tomas N Alme; Thor W R Hansen
Journal:  Mol Genet Metab Rep       Date:  2014-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.